Skip to content
RNAWiki
Checking…
All public datasets

Public dataset

Recorded source agreement and disagreement

Show whether sources print one normalized reading, have incompatible units, lack structured comparison context, or contain a context-matched numeric difference.

What this does not mean: agree can mean only that sources print the same normalized reading; it is not clinical-context equivalence, independent replication, or proof. differ requires matching structured context and disjoint comparable values. not_comparable and insufficient_context are not disagreement.
Public rows
1,681
Generated
Schema version
source-consensus/2

Coverage

What this run contains

Compared medicine fields
1,681
Agree
1,282
Differ
0
Not comparable
12
Insufficient context
387
Fields represented
5
bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution

Method

How the rows were made

  1. Deterministic rules normalize recorded pharmacokinetic readings and compare only like-for-like values.
  2. One normalized printed reading may be agree even when clinical context was not extracted; this reports printed-reading agreement only.
  3. Distinct readings may differ only when their units and denominators are comparable and one matching, non-placeholder population/formulation context was structurally extracted. Otherwise they are insufficient_context.
  4. not_comparable preserves incompatible units or denominators instead of guessing. insufficient_context preserves missing or non-matching structured context instead of manufacturing agreement or disagreement.
  5. The agreement rate describes the distribution of recorded source readings; it is not a probability that a value is true.
  6. Every distinct printed reading retains its unit, population context, source count, and complete source records. The API paginates field rows, never child readings or sources.
  7. documentsExamined is every matching single-substance archive document inspected for that medicine. The generator has no document, reading, or source ceiling, so there is no hidden available-versus-retained remainder.

Limits

Read these before using a row

  • Current label parsing does not structurally extract population or formulation context. Distinct otherwise-comparable readings are therefore insufficient_context, never differ; agree may mean printed-reading agreement only. Source records are complete but are not independent-experiment counts.
  • The current deterministic parser does not structurally extract population or formulation context from these sentences. It records that context as unknown and cannot publish distinct same-unit readings as differ.
  • Neither reading is marked wrong. Population, formulation, route, and other unextracted context may explain the printed difference.
  • Only the recorded fields and source documents in this snapshot are compared.
  • A source count is the number of retained source records in the row, not a count of independent experiments.

Provenance

Source examples

abacavir · bioavailability · agree

15 documents examined; 83% (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:5676d391-f9a4-44be-9604-954b3d8d0e2b (opens source in a new tab)
The geometric mean absolute bioavailability of the tablet was 83%.

alemtuzumab · volumeOfDistribution · not_comparable

2 documents examined; 0.18 L/kg (Unknown: population and formulation context were not structurally extracted from this source sentence.); 14.1 L (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:4f5f7255-7abc-4328-bd1a-ceaf139ef3e0 (opens source in a new tab)
Distribution After the last 30 mg dose, the mean volume of distribution at steady-state was 0.18 L/kg (range 0.1 to 0.4 L/kg).

abiraterone · halfLife · insufficient_context

31 documents examined; 12 ± 5 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.); 18 hours (Unknown: population and formulation context were not structurally extracted from this source sentence.)

FDA_LABEL:c9eb9b46-f847-40a8-802c-a51b40406d5a (opens source in a new tab)
Elimination In patients with metastatic CRPC, the mean terminal half-life of abiraterone in plasma (mean ± SD) is 12 ± 5 hours.

Artifact used for this view: data/source-consensus.ndjson. The reader resolves the current run first and uses the checked-in compatibility run only when a current artifact is absent.

Schema

Fields in the public projection

FieldTypeMeaning
medicineSlugstringStable RNAWiki medicine route key.
fieldstringRecorded pharmacokinetic field being compared.
comparisonStatestringagree (printed-reading agreement), differ (context-matched comparable disjoint values), not_comparable (unit/denominator mismatch), or insufficient_context. Every state remains declared even when its current count is zero.
comparisonReasonsstring[]Deterministic codes explaining the state.
documentsExaminednumberRecorded source documents considered for the field.
sourceCountnumberRecorded source readings represented.
agreementRatenumberShare represented by the leading normalized printed-reading group; not a confidence score or clinical agreement probability.
readingsconsensus-reading[]Complete, untruncated reading groups. Each keeps the printed display, numeric value when parsed, unit, population context, source count, and every source identity, version/effective date or explicit absence, retrieval date, locator, safe link, and excerpt.

Reader

Search and filter the rows

Case-insensitive text search over the public fields named for this dataset.

Exact comparability state.

Exact recorded field key.

Clear

Showing 491–500 of 1,681 matching rows. Filters and search terms remain attached when you move between pages or open the API view.

  1. Projected row 491

    Medicine slug
    droxidopa
    Compared field
    tMax
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    14
    Source count
    14
    Agreement rate
    1
    Recorded readings

    1. 2 hours

      Numeric value
      2
      Unit
      hours
      Source records
      14

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 14 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f6dce609-c7d7-48a3-83bb-32ecf00f973f (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ff263c9a-3db2-45ac-9ba6-8fca47199604 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:10b02d98-ebb8-4152-bd56-3402417fbf79 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6091958e-f04e-47c0-9eef-9c204df4edd9 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:51ef3096-4622-4f45-a180-ab0dc6d46df9 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:049f997b-1649-467e-bbb9-bdb991b0bc6e (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c21ea27c-6e3b-4296-a118-c0b878cdf8f8 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04b1f69d-ebba-43b9-8ecd-4f6be7c8a0a0 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c3cfd280-3548-b590-e053-2a95a90a5eb3 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aa3ce55a-1ea9-4b50-b682-6f25398bcc29 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics A b s o r p tion Peak plasma concentrations (C max ) of droxidopa were reached by 1 hours to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe08aebb-b390-d176-e053-6394a90a6be7 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81b798dc-b8dc-48a5-af46-82bb55f789a8 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (Cmax) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2179f02c-48d7-48eb-8007-5ae43d8d16bc (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Peak plasma concentrations (C max ) of droxidopa were reached by 1 to 4 hours post-dose (mean of approximately 2 hours) in healthy volunteers.

  2. Projected row 492

    Medicine slug
    droxidopa
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    14
    Source count
    14
    Agreement rate
    1
    Recorded readings

    1. 200 L

      Numeric value
      200
      Unit
      L
      Source records
      14

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 14 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f6dce609-c7d7-48a3-83bb-32ecf00f973f (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ff263c9a-3db2-45ac-9ba6-8fca47199604 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:381ffe44-d5d8-4380-a3cd-6d6a5e9ef55d (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:10b02d98-ebb8-4152-bd56-3402417fbf79 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6091958e-f04e-47c0-9eef-9c204df4edd9 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:51ef3096-4622-4f45-a180-ab0dc6d46df9 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:049f997b-1649-467e-bbb9-bdb991b0bc6e (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c21ea27c-6e3b-4296-a118-c0b878cdf8f8 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:04b1f69d-ebba-43b9-8ecd-4f6be7c8a0a0 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c3cfd280-3548-b590-e053-2a95a90a5eb3 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:aa3ce55a-1ea9-4b50-b682-6f25398bcc29 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fe08aebb-b390-d176-e053-6394a90a6be7 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:81b798dc-b8dc-48a5-af46-82bb55f789a8 (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2179f02c-48d7-48eb-8007-5ae43d8d16bc (opens source in a new tab)

        Droxidopa label

        Version not recorded · Effective date not recorded

        The estimated apparent volume of distribution of droxidopa is about 200 L in humans.

  3. Projected row 493

    Medicine slug
    dulaglutide
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    7
    Source count
    7
    Agreement rate
    1
    Recorded readings

    1. 5 days

      Numeric value
      Not parsed
      Unit
      Not recorded
      Source records
      7

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 7 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6088c732-afa1-4fee-9206-22e52baf4731 (opens source in a new tab)

        Dulaglutide label

        Version not recorded · Effective date not recorded

        The elimination half-life of dulaglutide was approximately 5 days.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a923e467-fea3-431c-b7e4-c9669af607b7 (opens source in a new tab)

        Dulaglutide label

        Version not recorded · Effective date not recorded

        The elimination half-life of dulaglutide was approximately 5 days.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:80d1e766-fefc-44b4-bec9-c7b0198ec08f (opens source in a new tab)

        Dulaglutide label

        Version not recorded · Effective date not recorded

        The elimination half-life of dulaglutide was approximately 5 days.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:58353438-3236-4596-9324-62fed9615cb7 (opens source in a new tab)

        Dulaglutide label

        Version not recorded · Effective date not recorded

        The elimination half-life of dulaglutide was approximately 5 days.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0a4716d0-9c9c-4bc3-a8f1-6784599aae89 (opens source in a new tab)

        Dulaglutide label

        Version not recorded · Effective date not recorded

        The elimination half-life of dulaglutide was approximately 5 days.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af4e38a6-ad3f-480c-ae82-5ac6c7735b99 (opens source in a new tab)

        Dulaglutide label

        Version not recorded · Effective date not recorded

        The elimination half-life of dulaglutide was approximately 5 days.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:463050bd-2b1c-40f5-b3c3-0a04bb433309 (opens source in a new tab)

        Dulaglutide label

        Version not recorded · Effective date not recorded

        The elimination half-life of dulaglutide was approximately 5 days.

  4. Projected row 494

    Medicine slug
    duloxetine
    Compared field
    halfLife
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    127
    Source count
    127
    Agreement rate
    0.992126
    Recorded readings

    1. 12 hours

      Numeric value
      12
      Unit
      hours
      Source records
      126

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 126 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b32a39d8-5f1a-4e44-bc46-b65925bde753 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:177ce798-3924-416b-ba37-23dfa911a43b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b1cac95-83e3-4fad-8d60-7a1a9e675eb2 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3fbdcc34-6166-4843-839c-33fed718ffb2 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c934cc41-b40b-4c5c-b019-a749eec52d88 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a5804a0b-ceae-4ebd-bba0-bfc10e21b90d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c482d64a-73dd-4af2-9b3c-efff47e7395c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:05a744a5-64ef-42d7-a19c-568be5a272d4 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a105a648-6a97-4151-b9de-d7eac90a8f79 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9286ec0b-45ae-4a09-a0ad-556ec92aab63 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3dec1805-9a95-462e-8784-303004d500b1 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3686cde5-f76d-4d16-aa5d-caceb8408f8c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:675f999d-46b2-45da-b17e-58cc2ba180b1 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a23e79b3-7bd3-4b83-beb0-dc23d4830e9e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5584c5ed-cab6-4c8b-8307-41e5d77704d0 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db85a82d-84f1-41c8-964b-ac94ae4d8e7b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3424a326-9543-44f7-b31c-f84e12509238 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:22a2ad76-0841-46fe-85e1-101afd924939 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b9f20917-9529-4c62-bafe-baae7f8d6c77 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:79bfd6be-a1ff-4786-b4e2-abbd0a3e3932 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4673ccdd-c86c-4ddc-b462-941897ecfd22 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c34f6115-f447-450f-8c83-58f3c51a76c9 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41c86c02-68c0-4db5-af1a-941b0d2ffe11 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c288791-2d8f-84bb-e063-6294a90a7e1e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b25c01e0-273a-4f8f-a37e-9b17e5cf378f (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5fa0eda4-0886-415c-a30c-ae9729f16974 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:29eacc40-cbec-4cc9-8556-773346617e85 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39fa4247-e864-f653-e063-6394a90ac98d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d3a45f3-3854-4d0c-9241-770aa24063fd (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00628e5e-4c5b-2573-e063-6294a90a0e3b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19afed24-39ad-daf1-e063-6394a90ad737 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7685a825-3c06-433d-ba98-4019c6ed2583 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c233b3f-83de-40c4-9f1d-81f901f89459 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41876761-9d5b-4190-a200-6a822c54582e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a8cb289-0332-4835-960f-32d273092d15 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f5e7503a-b28f-4cd0-a4ee-47bdca88d54b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db686a0a-9b2a-4017-8bd1-b981da47c2f3 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a95cc04c-58e9-487f-8992-ef30df03a3cd (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b6040e79-0bbd-41a3-ba86-2a360a41864c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54749431-430e-4532-97f7-4b1cd8dd252e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d7c2a64-2ce0-f222-e063-6294a90a9056 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:276ca221-354c-484d-93d5-0698cb2cfd56 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e0381ead-d8bc-43fa-9f12-e0fefcaf7f3d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2dde979d-b6f8-41d1-96fb-325c75ea3a74 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4e42a04a-ab8e-3ec9-e063-6394a90a4565 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9dab9154-b86f-40dc-a4d1-18e6534dbc78 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b149641a-03e6-4fee-91f3-7ba8e01196bd (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c66fb2ee-f64a-4d28-a692-e8dc7b61fbc9 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:461d769c-b787-4bc7-b4a6-7a5f33ae9d45 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:075fc7c9-7b4b-b9c3-e063-6394a90a926e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:71256b03-867f-4c5e-aa5d-75d1bb705fcb (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca36f94c-2215-436f-ada8-7319f4f3e054 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dcfd62c7-1687-4e9b-9ae4-5a44929ac765 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b1f1345c-3b7f-4228-b7b7-b9a4648050e5 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be33f3cb-6fd1-4377-816e-84bd49370e9e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df61b895-c358-827b-e053-2995a90a9b60 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41c54fb7-03f8-2326-e063-6394a90a6352 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3f649b01-0969-cc71-e063-6394a90a9df5 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fb37745f-fb40-4f7f-8143-ea1874c38e1b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:79e1a9b1-e084-48b6-a252-97bbd2f55a79 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:90224073-178d-7ec5-e053-2995a90a20fc (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        If symptoms of urinary hesitation develop during treatment with duloxetine delayed-release capsules, consideration should be given to the possibility that they might be drug-related. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b33cbab8-1962-cb66-e053-2a95a90a4ae7 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine delayed-release capsules appear to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:afd59273-75cb-5f33-e053-2995a90ab25f (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine delayed-release capsules appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7c755ca3-0855-4b54-80a8-01b85f8e644a (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3eb24fa9-921b-4bdb-9e0a-c82cb600df0f (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b19ba26f-4711-443e-83cf-5af7bb43a0a0 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f66f63c8-51db-4183-a452-78205cf3a263 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba4adb77-45be-4310-a877-766692f22e5e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b3b26383-9924-40f9-b4bb-43e30b70493e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac903bda-76af-4aba-9c8a-ebf7066e05ee (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4f205401-39ac-7009-e063-6394a90aaa8c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4121bd3f-2d6d-3bdd-e063-6294a90a3088 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8c0bc80-b34e-daa8-e053-6394a90a05c2 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5410084d-a7db-4da1-a45d-24b91ef50404 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:407b62b9-5b32-4bac-a2b0-7df499279248 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca376622-d32c-4e6e-8af4-8e24a8d20d83 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0c82422a-d493-4dda-8626-0d9baa25db8c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a891f20f-83ff-4960-81ef-9e74d01a452e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be0261c7-fb5e-4ba6-b7fb-13a1fecb5f75 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bae1317-4cc8-4d86-b1b6-15edee733a6d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e2352870-3582-4d92-8712-87ad8bdccb87 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fa5657a8-c6d9-474a-9d1a-b75b41b4327f (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ff118c08-2e64-4416-a996-fd9de45d018a (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cdd870a9-3bed-42fc-b175-48aed5321969 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:569582d5-cb6d-735e-e063-6394a90abfb6 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3adfceb3-5f89-4bcf-b874-e3cb572a98b6 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f16beb64-5878-486a-82ee-8e83e728f26c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:51c342c9-b9c6-467d-8fea-b73d72e3febc (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07a7dd8d-cbf8-4281-8583-d2d98711ed6c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af6f8abd-19ec-69e4-e053-2a95a90ab69e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e6477c41-97a2-45a7-94b5-487aa65199f6 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      93. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c877bb68-759f-4d45-8bef-872554da4551 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      94. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39453971-766d-45bf-a0fd-4658d72bae72 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      95. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9141b9d3-8d4d-43ec-acf9-e1b620590c4b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      96. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c52fc4ad-7bda-4824-8edf-117d3d8d6b3d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      97. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b61c261-d7f2-4f9d-e063-6294a90acc24 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      98. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b102b8e6-d58f-419c-bb35-720bafa13294 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      99. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39bb9e78-e550-4bf9-ba6a-b4d9c7beaeb7 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      100. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:726b3c3e-8266-4a8a-a426-899cecd4f87e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      101. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:22a8cc15-17fb-4c4e-8d2a-de5755ed6031 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      102. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e36a6919-568a-4d4a-9920-7a7fe4f3441c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      103. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2be9e5fb-011e-424b-b504-df2a28b5271d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      104. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4fa1d3b-f136-e14f-e053-2a95a90a6cfb (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      105. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c5aac428-d929-4688-a9d5-4e9314aa62cc (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      106. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c194a7b0-1e7e-a32b-e053-2995a90a7dbd (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      107. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:829a4f51-c882-4b64-81f3-abfb03a52ebe (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      108. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb2ca3bf-983c-1e4a-a91d-dc7dee66d741 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Elimination Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours).
      109. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9221f3e5-17b8-ea74-e053-2a95a90ad1a8 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      110. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed164dbb-e713-42d1-a78e-31145578b9f8 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      111. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e86eb765-ac9c-4ed9-bce8-819151559394 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      112. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e428429e-e1ea-40e1-870f-134533dc3aa1 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine delayed-release capsules appear to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      113. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1409fc2b-7252-472f-b719-e56141b36da2 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      114. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d942e38-90d4-de39-e063-6294a90a9822 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      115. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:caef6f50-1571-4ec7-8f8c-42b924d323ee (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      116. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0a48dfd-af34-470b-9e1f-7678203e9ae5 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      117. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b14feecc-04c6-4b2d-ba55-2e1dbef6b0d7 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      118. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39e293d5-c575-49db-8389-7ac2269c49bb (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      119. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b70035d4-5a3f-c5b5-e053-2995a90acac1 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      120. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7a7c67be-6800-4ec3-9072-1e0e390a854b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      121. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eab90059-ea1c-46c1-884d-c15e7c562a01 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      122. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3edce3bd-1102-5951-e063-6394a90ae6c5 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      123. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae381859-be09-43e1-8b56-d0d8f4b49020 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Duloxetine appears to be associated with concentration-dependent but not clinically meaningful QT shortening. 12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      124. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f61bd9f3-cd3d-4c76-a110-0f1dcba610af (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      125. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9221aea1-8de1-b94e-e053-2a95a90a1eae (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 hours to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.
      126. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31362045-201f-45f3-99f2-a5e322a0c30b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Duloxetine has an elimination half-life of about 12 hours (range 8 to 17 hours) and its pharmacokinetics are dose proportional over the therapeutic range.

    2. 12.4 hours

      Numeric value
      12.4
      Unit
      hours
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b41423b8-dfec-4d79-ba3c-e43a87803d85 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Mean terminal half-life was 12.4 hours (range 7.8 to 22.2 hour) in subjects receiving a single dose DRIZALMA SPRINKLE.

  5. Projected row 495

    Medicine slug
    duloxetine
    Compared field
    volumeOfDistribution
    Comparison state
    insufficient_context
    Reason codes
    • STRUCTURED_CONTEXT_MISSING
    Documents examined
    127
    Source count
    127
    Agreement rate
    0.992126
    Recorded readings

    1. 1640 L

      Numeric value
      1,640
      Unit
      L
      Source records
      126

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 126 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b32a39d8-5f1a-4e44-bc46-b65925bde753 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:177ce798-3924-416b-ba37-23dfa911a43b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b1cac95-83e3-4fad-8d60-7a1a9e675eb2 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3fbdcc34-6166-4843-839c-33fed718ffb2 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c934cc41-b40b-4c5c-b019-a749eec52d88 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a5804a0b-ceae-4ebd-bba0-bfc10e21b90d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c482d64a-73dd-4af2-9b3c-efff47e7395c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:05a744a5-64ef-42d7-a19c-568be5a272d4 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a105a648-6a97-4151-b9de-d7eac90a8f79 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9286ec0b-45ae-4a09-a0ad-556ec92aab63 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3dec1805-9a95-462e-8784-303004d500b1 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3686cde5-f76d-4d16-aa5d-caceb8408f8c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:675f999d-46b2-45da-b17e-58cc2ba180b1 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a23e79b3-7bd3-4b83-beb0-dc23d4830e9e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5584c5ed-cab6-4c8b-8307-41e5d77704d0 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db85a82d-84f1-41c8-964b-ac94ae4d8e7b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3424a326-9543-44f7-b31c-f84e12509238 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:22a2ad76-0841-46fe-85e1-101afd924939 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b9f20917-9529-4c62-bafe-baae7f8d6c77 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:79bfd6be-a1ff-4786-b4e2-abbd0a3e3932 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      21. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4673ccdd-c86c-4ddc-b462-941897ecfd22 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      22. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c34f6115-f447-450f-8c83-58f3c51a76c9 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      23. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41c86c02-68c0-4db5-af1a-941b0d2ffe11 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      24. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c288791-2d8f-84bb-e063-6294a90a7e1e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      25. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b25c01e0-273a-4f8f-a37e-9b17e5cf378f (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      26. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5fa0eda4-0886-415c-a30c-ae9729f16974 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      27. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:29eacc40-cbec-4cc9-8556-773346617e85 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      28. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39fa4247-e864-f653-e063-6394a90ac98d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      29. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1d3a45f3-3854-4d0c-9241-770aa24063fd (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      30. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:00628e5e-4c5b-2573-e063-6294a90a0e3b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      31. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19afed24-39ad-daf1-e063-6394a90ad737 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      32. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7685a825-3c06-433d-ba98-4019c6ed2583 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      33. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2c233b3f-83de-40c4-9f1d-81f901f89459 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      34. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41876761-9d5b-4190-a200-6a822c54582e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      35. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9a8cb289-0332-4835-960f-32d273092d15 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      36. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f5e7503a-b28f-4cd0-a4ee-47bdca88d54b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      37. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:db686a0a-9b2a-4017-8bd1-b981da47c2f3 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      38. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a95cc04c-58e9-487f-8992-ef30df03a3cd (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      39. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b6040e79-0bbd-41a3-ba86-2a360a41864c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      40. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:54749431-430e-4532-97f7-4b1cd8dd252e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      41. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d7c2a64-2ce0-f222-e063-6294a90a9056 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      42. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:276ca221-354c-484d-93d5-0698cb2cfd56 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      43. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e0381ead-d8bc-43fa-9f12-e0fefcaf7f3d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      44. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2dde979d-b6f8-41d1-96fb-325c75ea3a74 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      45. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4e42a04a-ab8e-3ec9-e063-6394a90a4565 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      46. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9dab9154-b86f-40dc-a4d1-18e6534dbc78 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      47. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b149641a-03e6-4fee-91f3-7ba8e01196bd (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      48. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c66fb2ee-f64a-4d28-a692-e8dc7b61fbc9 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      49. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:461d769c-b787-4bc7-b4a6-7a5f33ae9d45 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      50. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:075fc7c9-7b4b-b9c3-e063-6394a90a926e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      51. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:71256b03-867f-4c5e-aa5d-75d1bb705fcb (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      52. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca36f94c-2215-436f-ada8-7319f4f3e054 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      53. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:dcfd62c7-1687-4e9b-9ae4-5a44929ac765 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      54. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b1f1345c-3b7f-4228-b7b7-b9a4648050e5 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      55. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be33f3cb-6fd1-4377-816e-84bd49370e9e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      56. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:df61b895-c358-827b-e053-2995a90a9b60 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      57. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:41c54fb7-03f8-2326-e063-6394a90a6352 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      58. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3f649b01-0969-cc71-e063-6394a90a9df5 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      59. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fb37745f-fb40-4f7f-8143-ea1874c38e1b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      60. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:79e1a9b1-e084-48b6-a252-97bbd2f55a79 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      61. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:90224073-178d-7ec5-e053-2995a90a20fc (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      62. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b33cbab8-1962-cb66-e053-2a95a90a4ae7 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      63. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:afd59273-75cb-5f33-e053-2995a90ab25f (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      64. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7c755ca3-0855-4b54-80a8-01b85f8e644a (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      65. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3eb24fa9-921b-4bdb-9e0a-c82cb600df0f (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      66. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b19ba26f-4711-443e-83cf-5af7bb43a0a0 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      67. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f66f63c8-51db-4183-a452-78205cf3a263 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      68. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2f7d4d67-10c1-4bf4-a7f2-c185fbad64ba (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      69. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ba4adb77-45be-4310-a877-766692f22e5e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      70. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b3b26383-9924-40f9-b4bb-43e30b70493e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      71. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ac903bda-76af-4aba-9c8a-ebf7066e05ee (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      72. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4f205401-39ac-7009-e063-6394a90aaa8c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      73. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:4121bd3f-2d6d-3bdd-e063-6294a90a3088 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      74. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f8c0bc80-b34e-daa8-e053-6394a90a05c2 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      75. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:5410084d-a7db-4da1-a45d-24b91ef50404 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      76. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:407b62b9-5b32-4bac-a2b0-7df499279248 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      77. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ca376622-d32c-4e6e-8af4-8e24a8d20d83 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      78. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:0c82422a-d493-4dda-8626-0d9baa25db8c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      79. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a891f20f-83ff-4960-81ef-9e74d01a452e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      80. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:be0261c7-fb5e-4ba6-b7fb-13a1fecb5f75 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      81. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3bae1317-4cc8-4d86-b1b6-15edee733a6d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      82. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e2352870-3582-4d92-8712-87ad8bdccb87 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      83. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:fa5657a8-c6d9-474a-9d1a-b75b41b4327f (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      84. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ff118c08-2e64-4416-a996-fd9de45d018a (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      85. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:cdd870a9-3bed-42fc-b175-48aed5321969 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      86. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:569582d5-cb6d-735e-e063-6394a90abfb6 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      87. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3adfceb3-5f89-4bcf-b874-e3cb572a98b6 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      88. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:51c342c9-b9c6-467d-8fea-b73d72e3febc (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      89. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b41423b8-dfec-4d79-ba3c-e43a87803d85 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      90. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:07a7dd8d-cbf8-4281-8583-d2d98711ed6c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      91. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af6f8abd-19ec-69e4-e053-2a95a90ab69e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      92. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e6477c41-97a2-45a7-94b5-487aa65199f6 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      93. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c877bb68-759f-4d45-8bef-872554da4551 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      94. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39453971-766d-45bf-a0fd-4658d72bae72 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      95. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9141b9d3-8d4d-43ec-acf9-e1b620590c4b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      96. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c52fc4ad-7bda-4824-8edf-117d3d8d6b3d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      97. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2b61c261-d7f2-4f9d-e063-6294a90acc24 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      98. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b102b8e6-d58f-419c-bb35-720bafa13294 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      99. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39bb9e78-e550-4bf9-ba6a-b4d9c7beaeb7 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      100. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:726b3c3e-8266-4a8a-a426-899cecd4f87e (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      101. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:22a8cc15-17fb-4c4e-8d2a-de5755ed6031 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      102. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e36a6919-568a-4d4a-9920-7a7fe4f3441c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      103. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2be9e5fb-011e-424b-b504-df2a28b5271d (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      104. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4fa1d3b-f136-e14f-e053-2a95a90a6cfb (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      105. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c5aac428-d929-4688-a9d5-4e9314aa62cc (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      106. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c194a7b0-1e7e-a32b-e053-2995a90a7dbd (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      107. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:829a4f51-c882-4b64-81f3-abfb03a52ebe (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      108. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:bb2ca3bf-983c-1e4a-a91d-dc7dee66d741 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      109. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9221f3e5-17b8-ea74-e053-2a95a90ad1a8 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      110. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ed164dbb-e713-42d1-a78e-31145578b9f8 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      111. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e86eb765-ac9c-4ed9-bce8-819151559394 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      112. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e428429e-e1ea-40e1-870f-134533dc3aa1 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      113. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:1409fc2b-7252-472f-b719-e56141b36da2 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      114. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2d942e38-90d4-de39-e063-6294a90a9822 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      115. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:caef6f50-1571-4ec7-8f8c-42b924d323ee (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      116. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:d0a48dfd-af34-470b-9e1f-7678203e9ae5 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        The apparent volume of distribution averages about 1640 L.
      117. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b14feecc-04c6-4b2d-ba55-2e1dbef6b0d7 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      118. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:39e293d5-c575-49db-8389-7ac2269c49bb (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      119. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b70035d4-5a3f-c5b5-e053-2995a90acac1 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      120. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:7a7c67be-6800-4ec3-9072-1e0e390a854b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      121. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:eab90059-ea1c-46c1-884d-c15e7c562a01 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      122. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3edce3bd-1102-5951-e063-6394a90ae6c5 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      123. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae381859-be09-43e1-8b56-d0d8f4b49020 (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution: The apparent volume of distribution averages about 1640 L.
      124. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f61bd9f3-cd3d-4c76-a110-0f1dcba610af (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      125. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:9221aea1-8de1-b94e-e053-2a95a90a1eae (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.
      126. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:31362045-201f-45f3-99f2-a5e322a0c30b (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1640 L.

    2. 1,640 L

      Numeric value
      1,640
      Unit
      L
      Source records
      1

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 1 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f16beb64-5878-486a-82ee-8e83e728f26c (opens source in a new tab)

        Duloxetine label

        Version not recorded · Effective date not recorded

        Distribution The apparent volume of distribution averages about 1,640 L.

  6. Projected row 496

    Medicine slug
    dutasteride
    Compared field
    bioavailability
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    20
    Source count
    20
    Agreement rate
    1
    Recorded readings

    1. 60%

      Numeric value
      60
      Unit
      %
      Source records
      20

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 20 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ee1eef5-8ec7-46c1-b4fa-13184915448f (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f95c3fff-1e15-4ab8-a839-6a65a5828dbb (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85023ea5-af64-4b91-e053-2991aa0a3373 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:908832b2-21d6-48ae-89cb-f06687321f74 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af5e7d42-6953-4b7f-afac-257e9444b0a2 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ad309b1-4497-8b9b-e063-6394a90aa9b4 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af338f55-55c1-4034-9c27-c3564addf24e (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50924a17-b21d-40ca-b702-aa61bac7af90 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b32611f3-50ec-45bb-a671-ea10cec7829d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74f29982-2317-4d31-a324-fe99bd134c31 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:947644ea-bc35-41df-8a7a-874360c90192 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:28519a08-3bf8-98b9-e063-6394a90a03f7 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b6f8d1b-1759-4fbb-9b95-c20db803e1c2 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:40ddf119-b0a5-4375-9285-d50a24ed1532 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4bc56a1-e31c-44fb-bfb5-f77425ff1ea1 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:468df1b8-1f82-4328-a549-0a716ad1266d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:369f73b9-e032-4315-e063-6294a90a4ca1 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3285b390-f531-4e99-9bae-828ac66e874d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e537c60d-9ba2-4e7f-a405-2b915dcd7ead (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:170f01fe-5048-413c-b4cd-8311e1a2728a (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Absolute bioavailability in 5 healthy subjects is approximately 60% (range: 40% to 94%).

  7. Projected row 497

    Medicine slug
    dutasteride
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    20
    Source count
    20
    Agreement rate
    1
    Recorded readings

    1. 170 hours

      Numeric value
      170
      Unit
      hours
      Source records
      20

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 20 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ee1eef5-8ec7-46c1-b4fa-13184915448f (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f95c3fff-1e15-4ab8-a839-6a65a5828dbb (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85023ea5-af64-4b91-e053-2991aa0a3373 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:908832b2-21d6-48ae-89cb-f06687321f74 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af5e7d42-6953-4b7f-afac-257e9444b0a2 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ad309b1-4497-8b9b-e063-6394a90aa9b4 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af338f55-55c1-4034-9c27-c3564addf24e (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50924a17-b21d-40ca-b702-aa61bac7af90 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b32611f3-50ec-45bb-a671-ea10cec7829d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74f29982-2317-4d31-a324-fe99bd134c31 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:947644ea-bc35-41df-8a7a-874360c90192 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:28519a08-3bf8-98b9-e063-6394a90a03f7 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b6f8d1b-1759-4fbb-9b95-c20db803e1c2 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:40ddf119-b0a5-4375-9285-d50a24ed1532 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4bc56a1-e31c-44fb-bfb5-f77425ff1ea1 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:468df1b8-1f82-4328-a549-0a716ad1266d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:369f73b9-e032-4315-e063-6294a90a4ca1 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3285b390-f531-4e99-9bae-828ac66e874d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e537c60d-9ba2-4e7f-a405-2b915dcd7ead (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:170f01fe-5048-413c-b4cd-8311e1a2728a (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        In this single-dose trial, dutasteride half-life increased with age (approximately 170 hours in men aged 20 to 49 years, approximately 260 hours in men aged 50 to 69 years, and approximately 300 hours in men older than 70 years).

  8. Projected row 498

    Medicine slug
    dutasteride
    Compared field
    tMax
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    20
    Source count
    20
    Agreement rate
    1
    Recorded readings

    1. 2 to 3 hours

      Numeric value
      2
      Unit
      hours
      Source records
      20

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 20 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ee1eef5-8ec7-46c1-b4fa-13184915448f (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f95c3fff-1e15-4ab8-a839-6a65a5828dbb (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption: Following administration of a single 0.5 mg dose of a soft gelatin capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85023ea5-af64-4b91-e053-2991aa0a3373 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption: Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:908832b2-21d6-48ae-89cb-f06687321f74 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption: Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af5e7d42-6953-4b7f-afac-257e9444b0a2 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ad309b1-4497-8b9b-e063-6394a90aa9b4 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af338f55-55c1-4034-9c27-c3564addf24e (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50924a17-b21d-40ca-b702-aa61bac7af90 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b32611f3-50ec-45bb-a671-ea10cec7829d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Following administration of a single 0.5 mg dose of a soft gelatin capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74f29982-2317-4d31-a324-fe99bd134c31 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:947644ea-bc35-41df-8a7a-874360c90192 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption: Following administration of a single 0.5-mg dose of a soft gelatin capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:28519a08-3bf8-98b9-e063-6394a90a03f7 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b6f8d1b-1759-4fbb-9b95-c20db803e1c2 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:40ddf119-b0a5-4375-9285-d50a24ed1532 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4bc56a1-e31c-44fb-bfb5-f77425ff1ea1 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a soft gelatin capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:468df1b8-1f82-4328-a549-0a716ad1266d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Following administration of a single 0.5 mg dose of a soft gelatin capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:369f73b9-e032-4315-e063-6294a90a4ca1 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3285b390-f531-4e99-9bae-828ac66e874d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e537c60d-9ba2-4e7f-a405-2b915dcd7ead (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption Following administration of a single 0.5 mg dose of a soft gelatin capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:170f01fe-5048-413c-b4cd-8311e1a2728a (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        No clinically significant changes in adrenal hormone responses to adrenocorticotropic hormone (ACTH) stimulation were observed in a subset population (n = 13) of the 1-year healthy volunteer trial. 12.3 Pharmacokinetics Absorption Following administration of a single 0.5-mg dose of a capsule, time to peak serum concentrations (T max ) of dutasteride occurs within 2 to 3 hours.

  9. Projected row 499

    Medicine slug
    dutasteride
    Compared field
    volumeOfDistribution
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    20
    Source count
    20
    Agreement rate
    1
    Recorded readings

    1. 300 to 500 L

      Numeric value
      300
      Unit
      L
      Source records
      20

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 20 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ee1eef5-8ec7-46c1-b4fa-13184915448f (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:f95c3fff-1e15-4ab8-a839-6a65a5828dbb (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution: Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:85023ea5-af64-4b91-e053-2991aa0a3373 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution: Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:908832b2-21d6-48ae-89cb-f06687321f74 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution: Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      5. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af5e7d42-6953-4b7f-afac-257e9444b0a2 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      6. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:2ad309b1-4497-8b9b-e063-6394a90aa9b4 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      7. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:af338f55-55c1-4034-9c27-c3564addf24e (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      8. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:50924a17-b21d-40ca-b702-aa61bac7af90 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      9. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:b32611f3-50ec-45bb-a671-ea10cec7829d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      10. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:74f29982-2317-4d31-a324-fe99bd134c31 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      11. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:947644ea-bc35-41df-8a7a-874360c90192 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution: Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      12. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:28519a08-3bf8-98b9-e063-6394a90a03f7 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      13. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:6b6f8d1b-1759-4fbb-9b95-c20db803e1c2 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      14. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:40ddf119-b0a5-4375-9285-d50a24ed1532 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      15. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:c4bc56a1-e31c-44fb-bfb5-f77425ff1ea1 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      16. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:468df1b8-1f82-4328-a549-0a716ad1266d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      17. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:369f73b9-e032-4315-e063-6294a90a4ca1 (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      18. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:3285b390-f531-4e99-9bae-828ac66e874d (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      19. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:e537c60d-9ba2-4e7f-a405-2b915dcd7ead (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).
      20. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:170f01fe-5048-413c-b4cd-8311e1a2728a (opens source in a new tab)

        Dutasteride label

        Version not recorded · Effective date not recorded

        Distribution Pharmacokinetic data following single and repeat oral doses show that dutasteride has a large volume of distribution (300 to 500 L).

  10. Projected row 500

    Medicine slug
    edaravone
    Compared field
    halfLife
    Comparison state
    agree
    Reason codes
    • COMPATIBLE_VALUES_OVERLAP
    Documents examined
    5
    Source count
    4
    Agreement rate
    1
    Recorded readings

    1. 4.5 to 9 hours

      Numeric value
      4.5
      Unit
      hours
      Source records
      4

      Population and context: Unknown: population and formulation context were not structurally extracted from this source sentence.

      Show all 4 source records
      1. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:46452eb5-db17-400d-b25b-11844a11e711 (opens source in a new tab)

        Edaravone label

        Version not recorded · Effective date not recorded

        Elimination The mean terminal elimination half-life of edaravone is approximately 4.5 to 9 hours.
      2. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:19862ae9-d6e1-70e6-e063-6394a90ae749 (opens source in a new tab)

        Edaravone label

        Version not recorded · Effective date not recorded

        Elimination The mean terminal elimination half-life of edaravone is approximately 4.5 to 9 hours.
      3. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:a8245a98-2ccb-4062-b865-3aa348351b48 (opens source in a new tab)

        Edaravone label

        Version not recorded · Effective date not recorded

        Elimination The mean terminal elimination half-life of edaravone is approximately 4.5 to 9 hours.
      4. FDA_LABELRetrieved 2026-08-30
        FDA_LABEL:ae940bc6-1e6a-4b76-825c-bd2e1925e39a (opens source in a new tab)

        Edaravone label

        Version not recorded · Effective date not recorded

        Elimination The mean terminal elimination half-life of edaravone is approximately 4.5 to 9 hours.

Access

Query or download the projection

View this filtered page as JSONDownload up to 200 filtered CSV rows
GET /api/datasets/source-consensus?limit=10&offset=490

Allowed query parameters

q
Case-insensitive text search over the public fields named for this dataset.
state
Exact comparability state.Values: agree, differ, not_comparable, insufficient_context
field
Exact recorded field key.Values: bioavailability, halfLife, proteinBinding, tMax, volumeOfDistribution
limit / offset
Pagination is required. limit is at most 200; offset is bounded. Set format=csv for the same projected page as a download.

Reuse and corrections

Keep the boundary attached

CC BY 4.0 applies to RNAWiki licenses its selection, schema, structure, and derived projection. Quoted source passages and third-party records retain their original rights.

Cite RNAWiki, this dataset identifier, and the generated date. Keep the “does not mean” statement with any downstream display so a corpus measurement is not mistaken for medical advice.

Read the correction policy